CURA is excited to be launching our new product line, Xpeedy® SPEctra™, at this year's ADLM exposition. This cutting-edge solution features a high-sensitivity, magnetic beads-based extraction kit and a fully automated method for LC/MS analysis. Increa

We are thrilled to announce the success of our recent Open House event, held on June 2, 2025! The event welcomed partners, clients, colleagues, and community members to experience a behind-the-scenes look at the cutting-edge technology, passionate team, a

CURA Diagnostics proudly helped kickoff Asian American and Pacific Islander (AAPI) Heritage Month for HALEON with a compelling keynote from CEO Jia He, who served as the event's Spotlight Speaker. Her participation marked a powerful beginning to the m

We are very pleased to work with a local non-profit, Daily Planet Health Services. Through a recent donation aimed at supporting their mission to provide accessible health service to individuals in need. At CURA Diagnostics, we understand that the fight a

CURA Diagnostics has had an incredible year, marked by significant accomplishments and exciting new partnerships. As we wrap up this year and look forward to an even stronger start to the next, we are thrilled to introduce our new Vice President of Sales,

November 4th, 2024 – As Transversal Therapeutics (CURA owned subsidiary company) pursues non-dilutive funding opportunities in the drug toxicology space, we are excited to announce that we have recently received the notice of allowance for our patent appl

September 17th, 2024– As CURA enters the latter half of the year, we are pleased to announce the successful completion of our Pre-A series funding round. CURA has raised over $4 million, led by a prominent asset management firm. Underscoring strong confid

CURA is dedicated to building and sustaining strong partnerships, with a primary focus on delivering outstanding customer service and ensuring client satisfaction. As we continue to grow, we've successfully established enduring relationships on a glob

CURA Diagnostics is thrilled to announce their new partnership with Mercedes Scientific. As a leader in laboratory distribution, Mercedes Scientific has established itself as a top player in the industry through collaborations with leading diagnostic comp

CURA Diagnostics is very excited to announce another significant achievement! We have implemented our complete solution in Kentucky-based laboratory.The Laboratory has not only passed its state inspection but has done so flawlessly, without a single defic

CURA Diagnostics proudly announces the successful installation of our second A20 and complete laboratory solution at a new reference lab in Kentucky. This achievement underscores our commitment to delivering state-of-the-art solutions to advanced toxico

CURA Diagnostics has experienced a year of significant achievements and advancements. A standout among these triumphs has been the successful launch of A20 and comprehensive lab solutions, implemented across multiple laboratories. As we eagerly anticipa

Revolutionary Diagnostic System Ready for Routine Clinical Lab TestingCURA Diagnostics is thrilled to announce the successful installation of its groundbreaking A20 system at a U.S. client site. This achievement is a testament to the dedication and har

We're thrilled to introduce Dr. Qian Cheng as the newest member of CURA Diagnostics, joining us as our Chief Scientific Officer. With over a decade of experience in the toxicology field, including eight years as a board-certified Clinical Laboratory D

The inauguration of CURA Diagnostics' state-of-the-art R&D lab in Woburn, MA, marks a pivotal moment for the company. This facility revolutionizes and optimizes CURA's operations, propelling them towards enhanced efficiency and innovation.The key